November 20, 2019
Wall Street Journal: Biotech Startup Werewolf Therapeutics Hunts Down $56 Million
Biotechnology startup Werewolf Therapeutics Inc. gathered $56 million in venture financing to seek solutions to problems that have hindered a promising type of cancer immunotherapy.
Wall Street Journal
By Brian Gormley